Orange Book product · Generic (ANDA)
HALOBETASOL PROPIONATE AND TAZAROTENE
HALOBETASOL PROPIONATE; TAZAROTENE
Generic (ANDA)ANDA 217190TE ABRX SUN PHARMA CANADA
At a glance
May 02, 2025
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 02, 2025
1 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
HALOBETASOL PROPIONATE; TAZAROTENE
Strength
0.01%;0.045%
Dosage form
LOTION
Route
TOPICAL
TE code
AB
Application
ANDA 217190
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of HALOBETASOL PROPIONATE; TAZAROTENE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
